Literature DB >> 1539064

TRH protection against memory retrieval deficits is independent of endocrine effects.

S A Stwertka1, G P Vincent, E R Gamzu, D A MacNeil, A G Verderese.   

Abstract

An electrobrainshock (EBS)-induced memory retrieval deficit was produced in normal and hypophysectomized mice. In normal mice, thyrotropin-releasing hormone (TRH) (0.1 to 30 mg/kg) protected against this EBS disruption of memory after intraperitoneal but not oral (1.0 to 100 mg/kg) administration. In hypophysectomized mice, TRH (0.3 and 3.0 mg/kg) also protected against the retrieval deficit induced by EBS. The memory protection afforded by TRH was unrelated to its ability to elevate plasma levels of triiodothyronine (T3) and thyroxine (T4), nor was TRH's memory protection mediated through an anticonvulsive mechanism. These results support the notion that TRH may play an important role in memory modulation and may have therapeutic value in certain disease states in humans.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1539064     DOI: 10.1016/0091-3057(92)90074-p

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

1.  Functional characterization of 5-oxoproline transport via SLC16A1/MCT1.

Authors:  Shotaro Sasaki; Yuya Futagi; Masaki Kobayashi; Jiro Ogura; Ken Iseki
Journal:  J Biol Chem       Date:  2014-11-04       Impact factor: 5.157

2.  Effect of a thyrotrophin-releasing hormone analogue, RX77368, on AMPA-induced septal-hippocampal lesioned rats in an operant delayed non-matching to position test.

Authors:  T M Ballard; A J Hunter; G W Bennett
Journal:  Psychopharmacology (Berl)       Date:  1996-10       Impact factor: 4.530

3.  Differences in Hypothalamic Lipid Profiles of Young and Aged Male Rats With Impaired and Unimpaired Spatial Cognitive Abilities and Memory.

Authors:  Judith Wackerlig; Harald C Köfeler; Volker Korz; Ahmed M Hussein; Daniel D Feyissa; Harald Höger; Ernst Urban; Thierry Langer; Gert Lubec; Jana Lubec
Journal:  Front Aging Neurosci       Date:  2020-07-03       Impact factor: 5.750

4.  Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{N-[(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)-l-alanyl}-(2R)-2-methylpyrrolidine Trihydrate (Rovatirelin Hydrate).

Authors:  Naotake Kobayashi; Norihito Sato; Yuko Fujimura; Tsuyoshi Kihara; Katsuji Sugita; Kouji Takahashi; Katsumi Koike; Tamio Sugawara; Yukio Tada; Hiroshi Nakai; Takayoshi Yoshikawa
Journal:  ACS Omega       Date:  2018-10-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.